Respiratory system disorders
Breathing or respiration is the process of movement of air in and out of the lungs to
facilitate gases exchange with the internal environment.
During this process oxygen from atmosphere is exchanged with carbon dioxide
produced within the body.
Type
1. Infectious
2. Chronic
ASTHMA
• A chronic inflammatory disease of the airway in which variable
periodic symptoms occur, along with airflow obstruction and
bronchial hyper-responsiveness is termed ASTHMA.
Types
• Extrinsic :
this type is initiated by a type I hypersensitivity (Atopic)
response to an extrinsic antigen.
• Intrinsic :
This type is initiated by the nonimmune mechanism such as
respiratory tract infection, exercise, aspirin, emotional upset and
exposure to the bronchial irritants (cigarettes).
This classification of asthma is clinically non-beneficial since the
asthmatic patient experiences the symptoms of both intrinsic and
extrinsic asthma
1. Atopic Asthma
2. Non-atopic Asthma
3. Drug induced Asthma
4. Occupational Asthma
1. Atopic Asthma
• This is type I IgE mediated hypersensitivity reaction.
• Very common in childhood beginning
• Its due to dust, pollen, animal danger, food, infection
• Diagnosis involved in serum Radioallergosorbent test (RASTs) to
determine the presence of IgE which recognized specific allergens.
2. Non atopic asthma
• Asthmatic patient do not show allergen sensitisation and the skin test
for diagnosis are negative
• It is caused by viral respiratory infection like rhinovirus and para
influenza virus and inhaled air pollutant like a sulphur dioxide, ozone,
nitrogen dioxide
3. Drug induced asthma
• It is caused by certain pharmacological agents like aspirin
• Aspirin sensitive patients shows periodic rhinitis, nasal polyps,
bronchospasm.
4. Occupational Asthma
• Caused by a fumes (epoxy resins and plastics).
• Organic and chemical dust like wood cotton and platinum, in gases
toluene
Etiology
1. Indoor allergens ( house dust, mites in bedding, carpets)
2. Outdoor allergens ( pollens and moulds )
3. Tabacco smokes
4. Chemical irritants in the workplace
5. Air pollution.
Pathogenesis
Two type of reaction are produced by these mast cell derived
mediators.
• Early Phase or intermediate Reaction:
• Late Phase Reaction
Early phase or intermediated reaction
• Bronchoconstriction, increase mucus production, and vasodilation are
the chief characteristics of this reaction.
• Mast cell derived mediators (histamine, prostaglandin D2 and
leukotrienes) and reflex neural pathway cause bronchoconstriction.
Late Phase Reaction
• This rection is inflammation and the mediators stimulate production
of chemokines (such as eotaxin, a potent chemo attractant, and
eosinophils activator) by the epithelial cells.
• Chemokines allows the involvement of TH2 cells, eosinophils and
other leukocytes, which strengthen the inflammatory reaction
initiated by the local immune cells.
Signs and Symptoms
• Coughing
• Wheezing
• Breathlessness
• A feel of tightness, pain, pressure in chest
Complication
• Status asthmaticus : airway remains block for prolonged periods also do
not respond to treatment
• Pneumonia
• Atelectasis : part of lungs collapse due to large amount of mucus in lungs
• Respiratory failure : oxygen get decrease and carbon dioxide get increases
• Underperformances and fatigue
• Absenteeism
• Anxiety
Diagnosis
• Personal and medical history
• Physical Examination
• Lung function
1. Spirometry : patient is asked to take a deep breath and then
exhaled forcefully into a mouthpiece connected to a spirometer
2. Peak airflow : small handheld device measures the rate at which
patient forces air out of the lungs
3. Trigger tests
Plan of treatment
Medication
1. Long term asthma control medication
• Inhaled corticosteroids : fluticasone
• Leukotriene modifiers : montelukast, zafirlukast
• Long acting B Agonist : salmeterol, formoterol
• Combination inhaled : fluticasone-salmeterol
• Theophylline : bronchodilator
2. Quick Relief (Rescue) Medications
• Short Acting B Agonists
• Ipratropium
3. Allergy Medication
• Allergy Shots (immunotherapy)
• Omalizumab
Chronic Obstructive Pulmonary Disorder
(COPD)

Respiratory System HAP 1. b pharmacy pptx

  • 1.
    Respiratory system disorders Breathingor respiration is the process of movement of air in and out of the lungs to facilitate gases exchange with the internal environment. During this process oxygen from atmosphere is exchanged with carbon dioxide produced within the body. Type 1. Infectious 2. Chronic
  • 3.
    ASTHMA • A chronicinflammatory disease of the airway in which variable periodic symptoms occur, along with airflow obstruction and bronchial hyper-responsiveness is termed ASTHMA.
  • 4.
    Types • Extrinsic : thistype is initiated by a type I hypersensitivity (Atopic) response to an extrinsic antigen. • Intrinsic : This type is initiated by the nonimmune mechanism such as respiratory tract infection, exercise, aspirin, emotional upset and exposure to the bronchial irritants (cigarettes).
  • 5.
    This classification ofasthma is clinically non-beneficial since the asthmatic patient experiences the symptoms of both intrinsic and extrinsic asthma 1. Atopic Asthma 2. Non-atopic Asthma 3. Drug induced Asthma 4. Occupational Asthma
  • 6.
    1. Atopic Asthma •This is type I IgE mediated hypersensitivity reaction. • Very common in childhood beginning • Its due to dust, pollen, animal danger, food, infection • Diagnosis involved in serum Radioallergosorbent test (RASTs) to determine the presence of IgE which recognized specific allergens.
  • 8.
    2. Non atopicasthma • Asthmatic patient do not show allergen sensitisation and the skin test for diagnosis are negative • It is caused by viral respiratory infection like rhinovirus and para influenza virus and inhaled air pollutant like a sulphur dioxide, ozone, nitrogen dioxide
  • 9.
    3. Drug inducedasthma • It is caused by certain pharmacological agents like aspirin • Aspirin sensitive patients shows periodic rhinitis, nasal polyps, bronchospasm. 4. Occupational Asthma • Caused by a fumes (epoxy resins and plastics). • Organic and chemical dust like wood cotton and platinum, in gases toluene
  • 10.
    Etiology 1. Indoor allergens( house dust, mites in bedding, carpets) 2. Outdoor allergens ( pollens and moulds ) 3. Tabacco smokes 4. Chemical irritants in the workplace 5. Air pollution.
  • 11.
    Pathogenesis Two type ofreaction are produced by these mast cell derived mediators. • Early Phase or intermediate Reaction: • Late Phase Reaction
  • 12.
    Early phase orintermediated reaction • Bronchoconstriction, increase mucus production, and vasodilation are the chief characteristics of this reaction. • Mast cell derived mediators (histamine, prostaglandin D2 and leukotrienes) and reflex neural pathway cause bronchoconstriction.
  • 13.
    Late Phase Reaction •This rection is inflammation and the mediators stimulate production of chemokines (such as eotaxin, a potent chemo attractant, and eosinophils activator) by the epithelial cells. • Chemokines allows the involvement of TH2 cells, eosinophils and other leukocytes, which strengthen the inflammatory reaction initiated by the local immune cells.
  • 15.
    Signs and Symptoms •Coughing • Wheezing • Breathlessness • A feel of tightness, pain, pressure in chest
  • 16.
    Complication • Status asthmaticus: airway remains block for prolonged periods also do not respond to treatment • Pneumonia • Atelectasis : part of lungs collapse due to large amount of mucus in lungs • Respiratory failure : oxygen get decrease and carbon dioxide get increases • Underperformances and fatigue • Absenteeism • Anxiety
  • 18.
    Diagnosis • Personal andmedical history • Physical Examination • Lung function 1. Spirometry : patient is asked to take a deep breath and then exhaled forcefully into a mouthpiece connected to a spirometer 2. Peak airflow : small handheld device measures the rate at which patient forces air out of the lungs 3. Trigger tests
  • 19.
    Plan of treatment Medication 1.Long term asthma control medication • Inhaled corticosteroids : fluticasone • Leukotriene modifiers : montelukast, zafirlukast • Long acting B Agonist : salmeterol, formoterol • Combination inhaled : fluticasone-salmeterol • Theophylline : bronchodilator
  • 20.
    2. Quick Relief(Rescue) Medications • Short Acting B Agonists • Ipratropium 3. Allergy Medication • Allergy Shots (immunotherapy) • Omalizumab
  • 21.